Remote ECG monitoring as a diagnostic tool for therapeutic strategies after transcatheter aortic valve replacement: rationale and design of the DRAGON-TAVI randomized trial

Scritto il 25/06/2026
da Paulina Lis

No abstract

Cardiol J. 2026;33:e00226061. doi: 10.5603/cj.111069.

NO ABSTRACT

PMID:42347919 | DOI:10.5603/cj.111069